Development of engineered cells for implantation in gene therapy
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 33 (1-2) , 31-43
- https://doi.org/10.1016/s0169-409x(98)00018-0
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Nonautologous Somatic Gene TherapyPublished by Taylor & Francis ,2018
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsNature Genetics, 1997
- Transplantation of Gunn Rats with Autologous Fibroblasts Expressing Bilirubin UDP-Glucuronosyltransferase: Correction of Genetic Deficiency and Tumor FormationHuman Gene Therapy, 1997
- Gene Therapy in the United States: A Five-Year Status ReportHuman Gene Therapy, 1996
- Gene Therapy — A Novel Form of Drug DeliveryNew England Journal of Medicine, 1995
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient PatientsScience, 1995
- Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiencyNature Medicine, 1995
- Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemiaNature Genetics, 1994
- Implantation of Genetically Engineered Fibroblasts into Mice: Implications for Gene TherapyScience, 1987